These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 5125988)

  • 1. [Fluctuations of portal pressure under normal conditions and evaluation of the severity of portal hypertension in liver cirrhosis].
    Mansurov KhKh
    Ter Arkh; 1971 Jul; 43(6):65-9. PubMed ID: 5125988
    [No Abstract]   [Full Text] [Related]  

  • 2. [Portal hypertension in the absence of liver cirrhosis and extrahepatic circulatory blockade].
    Bykov VS
    Klin Med (Mosk); 1981 Oct; 59(10):22-6. PubMed ID: 7031355
    [No Abstract]   [Full Text] [Related]  

  • 3. Transient elastography for diagnosis of portal hypertension in liver cirrhosis: is there still a role for hepatic venous pressure gradient measurement?
    Lim JK; Groszmann RJ
    Hepatology; 2007 May; 45(5):1087-90. PubMed ID: 17464984
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hypersplenism and portal hypertension].
    Lehoczky D
    Z Gesamte Inn Med; 1971 Oct; 26(19):Suppl:264-8. PubMed ID: 5147811
    [No Abstract]   [Full Text] [Related]  

  • 5. [Physiopathology of portal hypertension in liver cirrhosis].
    Cervela LA
    Rev Esp Enferm Apar Dig; 1973 Jan; 39(2):223-38. PubMed ID: 4690385
    [No Abstract]   [Full Text] [Related]  

  • 6. [Spironolactone in the treatment of portal hypertension in liver cirrhosis. A new therapeutic principle?].
    Klein CP
    Dtsch Med Wochenschr; 1985 Nov; 110(46):1774-6. PubMed ID: 4054003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanism of development of portal hypertension in liver cirrhosis].
    Kalashnikov SA
    Klin Med (Mosk); 1975 Apr; 53(4):74-8. PubMed ID: 1152376
    [No Abstract]   [Full Text] [Related]  

  • 8. [Estimation of portal pressure in cirrhotic patients by biochemical parameters: study of multiple correlations].
    González Reimers CE; Santolaria Fernández F; Jorge Hernández JA; Batista López N; de Armas Trujillo D; Hernández Nieto L
    Med Clin (Barc); 1982 Oct; 79(6):264-7. PubMed ID: 7144313
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cirrhosis of the liver without portal hypertension (author's transl)].
    Cortinovis A; Crippa A; Bellorini R
    Chir Ital; 1980 Oct; 32(5):996-1005. PubMed ID: 7249193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic venous pressure gradient in 2010: optimal measurement is key.
    Burroughs AK; Thalheimer U
    Hepatology; 2010 Jun; 51(6):1894-6. PubMed ID: 20512984
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of Hypostin infusion on the pressure of hepatic vein occlusion in portal hypertension].
    Machill K; Seifert A; Zellerhoff W
    Z Gesamte Inn Med; 1972 Aug; 27(15):668-71. PubMed ID: 4641143
    [No Abstract]   [Full Text] [Related]  

  • 12. [Intrahepatic portal hypertensive syndrome].
    Harada A; Nonami T; Takagi H
    Ryoikibetsu Shokogun Shirizu; 1995; (8):202-6. PubMed ID: 8581607
    [No Abstract]   [Full Text] [Related]  

  • 13. [Implications of the arterialization of the sinusoid in its capillarization and in the maintenance of portal hypertension in the cirrhotic patient].
    Ceña Lázaro G; Barrao Comps F; Omiste Martínez JL; Ducóns García J; Rojo Puente S; Laquidaín Hergueta M; Bueno Gómez J
    Rev Esp Enferm Apar Dig; 1987 Feb; 71(2):111-3. PubMed ID: 3563042
    [No Abstract]   [Full Text] [Related]  

  • 14. [Blocked suprahepatic pressure and the portohepatic gradient in evaluation of the portal circulation (author's transl)].
    Cortinovis A; Crippa A; Bellorini R; Pedroni G
    Chir Ital; 1980 Oct; 32(5):964-85. PubMed ID: 7018716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis.
    Schneider AW; Kalk JF; Klein CP
    Hepatology; 1999 Feb; 29(2):334-9. PubMed ID: 9918907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of sonographic representation of the portal artery in clinical practice].
    Fuchs KF; Dempe A; Bauch KH
    Z Gesamte Inn Med; 1983 Oct; 38(19):194-5. PubMed ID: 6649725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical approach to portal hypertension].
    González Galilea A; Fraga Rivas E; Miño Fugarolas G
    An Med Interna; 2000 Sep; 17(9):496-503. PubMed ID: 11100539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum laminin P1 levels do not reflect critically elevated portal pressure in patients with liver cirrhosis.
    Bahr MJ; Böker KH; Horn W; Günzler V; Manns MP
    Hepatogastroenterology; 1997; 44(16):1200-5. PubMed ID: 9261625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of action of isosorbide-5-mononitrate in reducing portal pressure in cirrhotic patients with cirrhosis and portal hypertension.
    Jenkins SA; Shields R
    J Gastroenterol Hepatol; 1991; 6(1):91-3. PubMed ID: 1883984
    [No Abstract]   [Full Text] [Related]  

  • 20. [Presinusoidal portal hypertension in post-hepatitis cirrhosis].
    Fraitag B; Barbier JP; Taibi N; Choudat D; Haas C; Carnot F
    Ann Med Interne (Paris); 1983; 134(4):339-41. PubMed ID: 6412611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.